Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
Return to Top
Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia.
Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia. Blood Adv. 2019 01 08; 3(1):96-104.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Clinical Studies as Topic
Drug Evaluation, Preclinical
Drug Resistance, Neoplasm
Humans
Molecular Targeted Therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Prognosis
Recurrence
Sialic Acid Binding Ig-like Lectin 2
Treatment Outcome
authors with profiles
Wendy Stock